Reduction of hepatic insulin-like growth factor I (IGF-I) messenger ribonucleic acid (mRNA) during fasting is associated with diminished splicing of IGF-I pre-mRNA and decreased stability of cytoplasmic IGF-I mRNA

被引:39
|
作者
Zhang, JH [1 ]
Chrysis, D [1 ]
Underwood, LE [1 ]
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
关键词
D O I
10.1210/en.139.11.4523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which fasting decreases liver insulin-like growth factor I(IGF-I) messenger RNA (mRNA) abundance have not been defined completely. In the present study, we have examined the effects of fasting in rats on hepatic IGF-I gene transcription, IGF-I pre-mRNA splicing, and cytoplasmic IGF-I mRNA stability. Using the in vitro nuclear run-on transcription technique, we observed that fasting did not change IGF-I gene transcription activity [76 +/- 32 densitometric units (DU) for fasted us. 58 +/- 23 DU for control-fed rats; P = 0.1], whereas IGF-binding protein-1 (IGFBP-1) gene transcription, a positive control, was increased more than a-fold (729 +/- 157 DU for fasted vs. 261 +/- 56 DU for control-fed rats; P < 0.05). This implies that fasting-induced reduction of liver IGF-I mRNA is due to events other than a decreased rate of IGF-I gene transcription. By measuring nonspliced (pre-mRNA) and spliced IGF-I transcripts in liver nuclear RNA using ribonuclease protection assays, we found that IGF-I pre-mRNA was increased in fasted rats (measured as the percentage of p-actin: 34.0 +/- 5.5% for fasted vs. 8.1 +/- 3.8% for control-fed rats; P < 0.01), whereas spliced IGF-I transcript remained unchanged (measured as the percentage of beta-actin: 60.9 +/- 9.2% for fasted us. 79.0 +/- 6.2% for control-fed rats; P = 0.75). We then compared this pattern of splicing to IGF-I pre-mRNA splicing in hypophysectomized rats subjected to GH stimulation and to IGFBP-1 pre-mRNA splicing in the same fasting experiment. One hour after GH injection, we observed a coordinate increase in both nonspliced and spliced IGF-I transcripts in liver nuclei of hypophysectomized rats. Easting increased both IGFBP-1 pre-mRNA and spliced transcript. Taken together, these results indicate that the increase in IGF-I pre-mRNA in liver nuclei during fasting is caused by delayed pre-mRNA splicing, rather than increased IGF-I gene transcription. To examine the possible effect of fasting on hepatic IGF-I mRNA stability, we used an in vitro model of nutrient deprivation (fewer amino acids in culture medium) of rat hepatocyte primary culture. Each of the three major IGF-I mRNA species exhibited a shortened half-life in the amino acid-deprived media. The 7.5-kb IGF-I mRNA, however, was degraded faster than the two smaller IGF-I mRNA species. This may indicate that fasting decreases the stability of liver IGF-I mRNA in vivo. In summary, these results suggest that fasting regulates hepatic IGF-I gene expression mainly at the posttranscriptional level by delaying IGF-I pre-mRNA splicing, which attenuates mature IGF-I mRNA generation, and by accelerating the rate of degradation of IGF-I mRNA in cytoplasm.
引用
收藏
页码:4523 / 4530
页数:8
相关论文
共 50 条
  • [21] CHARACTERIZATION OF THE AFFINITIES OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS 1-4 FOR IGF-I, IGF-II, IGF-I/INSULIN HYBRID, AND IGF-I ANALOGS
    OH, Y
    MULLER, HL
    LEE, DY
    FIELDER, PJ
    ROSENFELD, RG
    ENDOCRINOLOGY, 1993, 132 (03) : 1337 - 1344
  • [22] Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism
    Wilson, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11): : 4013 - 4021
  • [23] INSULIN-LIKE GROWTH FACTOR-I (IGF-I) RECEPTORS AND IGF-I ACTION IN OLIGODENDROCYTES FROM RAT BRAINS
    MASTERS, BA
    WERNER, H
    ROBERTS, CT
    LEROITH, D
    RAIZADA, MK
    REGULATORY PEPTIDES, 1991, 33 (02) : 117 - 131
  • [24] INSULIN-LIKE GROWTH FACTOR-I (IGF-I) EXPRESSION AND A NOVEL IGF-I RELATED ACTIVITY IN HUMAN MALIGNANCY
    YEE, D
    FAVONI, RE
    HUFF, KK
    PAIK, S
    DICKSON, RB
    LEBOVIC, GS
    SCHWARTZ, A
    LIPPMAN, ME
    ROSEN, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 54 - 54
  • [25] Hepatic insulin-like growth factor-I (IGF-I) receptor and mRNA expression in experimental hepatocellular carcinoma (HCC).
    Mckillop, IH
    Johnson, T
    Sabharwal, P
    Schmidt, CM
    Cahill, PA
    Sitzmann, JV
    FASEB JOURNAL, 1997, 11 (03): : 2482 - 2482
  • [26] Evolution of insulin-like growth factor-I (IGF-I) action: in vitro characterization of vertebrate IGF-I proteins
    Upton, Z
    Yandell, CA
    Degger, BG
    Chan, SJ
    Moriyama, S
    Francis, GL
    Ballard, FJ
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1998, 121 (01): : 35 - 41
  • [27] ANABOLIC EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND AN IGF-I VARIANT IN NORMAL FEMALE RATS
    TOMAS, FM
    KNOWLES, SE
    CHANDLER, CS
    FRANCIS, GL
    OWENS, PC
    BALLARD, FJ
    JOURNAL OF ENDOCRINOLOGY, 1993, 137 (03) : 413 - 421
  • [28] IDENTIFICATION OF THE INSULIN-LIKE GROWTH FACTOR-I (IGF-I) EPITOPES RECOGNIZED BY MONOCLONAL AND POLYCLONAL ANTIBODIES TO IGF-I
    CASCIERI, MA
    BAYNE, ML
    BER, E
    GREEN, BG
    MEN, GW
    CHICCHI, GG
    ENDOCRINOLOGY, 1990, 126 (06) : 2773 - 2777
  • [29] INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) AND THE IGF-I RECEPTOR PREVENT ETOPOSIDE-INDUCED APOPTOSIS
    SELL, C
    BASERGA, R
    RUBIN, R
    CANCER RESEARCH, 1995, 55 (02) : 303 - 306
  • [30] How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy
    Quarmby, V
    Quan, C
    Ling, V
    Compton, P
    Canova-Davis, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1211 - 1216